Name | adenomatosis polyposis coli |
Symbol | APC |
Aliases | GS; DP2; DP3; FAP; FPC; DP2.5 |
Gene Product | - adenomatosis polyposis coli
|
Category | - Methylation in Prostate cancer
- Mutation in Prostate cancer
|
UniGene | Hs.75081 |
OMIM | 175100 |
Locus | 324 |
Summary | The metabolic function of the APC gene is not known. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. |
Gene Ontology | |
Expression | EST (227 ESTs, 90 libraries) |
Tissue ? |
Frequency ? |
Count ? |
blood (4/27) |  | 5/40686 |
bone (1/13) |  | 2/26211 |
bone marrow (2/263) |  | 2/38555 |
brain (12/204) |  | 73/362011 |
cartilage (1/5) |  | 1/11018 |
cervix (1/7) |  | 1/28115 |
colon (4/853) |  | 4/165626 |
ear (1/2) |  | 2/12660 |
embryo (1/19) |  | 7/37976 |
eye (2/33) |  | 6/93836 |
foreskin (1/4) |  | 5/20040 |
germ cell (1/7) |  | 1/57383 |
head and neck (2/990) |  | 3/79796 |
heart (2/22) |  | 3/55494 |
intestine (1/4) |  | 1/11528 |
kidney (2/86) |  | 3/132968 |
liver (1/38) |  | 1/46472 |
lung (5/312) |  | 5/245386 |
muscle (2/21) |  | 6/71297 |
nervous (5/475) |  | 8/43438 |
oral cavity (1/18) |  | 5/44567 |
ovary (2/144) |  | 3/81880 |
pancreas (1/33) |  | 1/117255 |
placenta (2/342) |  | 3/157762 |
skin (1/31) |  | 2/100815 |
testis (5/171) |  | 22/117531 |
uncharacterized tissue (21/1773) |  | 42/713325 |
uterus (4/212) |  | 7/155110 |
|
SAGE (13062749 tags, 246 libraries) |
Tissue ? |
Frequency ? |
Count ? |
blood (1/1) |  | 4/145569 |
brain (18/19) |  | 203/2866610 |
cerebellum (1/1) |  | 6/256400 |
colon (8/8) |  | 88/1260636 |
eye (4/6) |  | 24/1490641 |
foreskin (2/2) |  | 2/19256 |
heart (1/1) |  | 1/84357 |
kidney (2/2) |  | 9/189727 |
lung (1/1) |  | 4/178286 |
mammary gland (15/19) |  | 145/1025313 |
muscle (2/2) |  | 3/161581 |
ovary (9/10) |  | 49/883482 |
pancreas (8/8) |  | 51/385838 |
prostate (13/13) |  | 125/938410 |
skin (1/7) |  | 1/12817 |
stomach (2/3) |  | 6/409395 |
uncharacterized tissue (18/22) |  | 168/2380929 |
vascular (3/3) |  | 15/373502 |
|
|
SNP | rs377860 (G/T:coding-nonsyn);  rs2253987 (C/T:intron);  rs918397 (A/C:intron);  rs458492 (A/G:intron);  rs391816 (A/C:locus-region);  rs2952615 (T/C:intron);  rs1882619 (C/T:locus-region);  rs1697914 (T/C:locus-region);  rs459552 (A/T:coding-nonsyn);  rs464338 (C/G:locus-region);  rs2909958 (A/G:intron);  rs548710 (T/C:intron);  rs392907 (G/A:intron);  rs395266 (T/C:intron);  rs1804197 (A/C:mrna-utr);  rs1801155 (G/C:coding-nonsyn);  rs42427 (A/G:coding-nonsyn);  rs1966476 (A/C:intron);  rs2546106 (T/A:intron);  rs544243 (T/G:intron);  rs464002 (A/G:locus-region);  rs2545169 (G/A:intron);  rs551052 (G/A:intron);  rs2901844 (A/G:intron);  rs2652288 (T/C:coding-nonsyn);  rs2416295 (A/G:intron);  rs1816769 (C/G:intron);  rs376845 (C/A:locus-region);  rs2439589 (C/T:intron);  rs1616230 (A/G:locus-region);  rs415045 (A/T:locus-region);  rs861674 (T/A:locus-region);  rs1974786 (C/G:locus-region);  rs1807226 (C/T:intron);  rs569940 (T/C:intron);  rs2707761 (C/G:intron);  rs2229993 (C/G:coding-nonsyn);  rs2464801 (T/C:locus-region);  rs399574 (A/C:intron);  rs448475 (C/G:mrna-utr);  rs1109248 (A/T:intron);  rs458906 (G/C:intron);  rs396321 (C/T:intron);  rs414362 (C/T:locus-region);  rs419537 (C/T:locus-region);  rs1734242 (C/G:locus-region);  rs2545154 (A/G:intron);  rs469336 (G/C:locus-region);  rs1644239 (A/G:locus-region);  rs1803556 (G/T:coding-nonsyn);  rs454886 (C/T:intron);  rs1661032 (T/C:locus-region);  rs401908 (T/C:intron);  rs2431238 (A/G:intron);  rs436108 (A/C:intron);  rs2455294 (G/A:locus-region);  rs2304792 (A/G:intron);  rs464708 (G/T:intron);  rs414098 (A/G:intron);  rs511906 (T/C:intron);  rs1465910 (A/G:locus-region);  rs380589 (T/C:intron);  rs817584 (T/C:locus-region);  rs467033 (T/A:intron);  rs563556 (G/C:intron);  rs866006 (A/C:coding-nonsyn);  rs2112210 (A/G:locus-region);  rs1049291 (C/T:locus-region);  rs1822163 (C/T:locus-region);  rs460197 (A/C:intron);  rs1441375 (A/G:locus-region);  rs389657 (A/G:intron);  rs458967 (C/T:intron);  rs2019720 (A/G:locus-region);  rs397768 (G/A:mrna-utr);  rs411356 (T/C:intron);  rs517947 (A/C:intron);  rs390092 (A/C:intron);  rs1914 (A/T:intron);  rs468293 (T/G:locus-region);  rs2431505 (T/C:intron);  rs2909784 (C/G:intron);  rs1922663 (C/T:locus-region);  rs392179 (A/G:intron);  rs2251913 (A/G:intron);  rs2546116 (T/A:intron);  rs375377 (T/C:locus-region);  rs501250 (C/G:intron);  rs2545158 (A/G:intron);  rs466901 (C/T:intron);  rs1613148 (A/G:intron);  rs366913 (T/C:intron);  rs465687 (T/C:intron);  rs351771 (G/A:intron);  rs369952 (G/A:intron);  rs41115 (C/T:mrna-utr);  rs2289484 (T/G:intron);  rs465899 (T/C:coding-nonsyn);  rs3068629 (TCTG/-:intron);  rs2020383 (C/T:locus-region);   |
Evidence | Methylation in Prostate cancer
Mutation in Prostate cancer
|